Refine by
Infusion Therapy Articles & Analysis
16 news found
Clinical data support preclinical observations that this gene therapy approach after HSCT infusion may lessen many of the immune challenges previously observed with systemic AAV gene delivery and may create a safer environment for gene replacement. ...
Vincent's Hospital, Melbourne, Australia. The jointly developed therapy features a micro-infusion device that tightly controls drug delivery to a region of the brain for patients with medically refractory epilepsy. ...
“Now more than ever, it is critical that we equip and empower clinicians with the safest, most effective, and connected infusion equipment possible,” said Pete Allen, senior vice president, Nutrition and Infusion Therapy, Fresenius Kabi USA. “With the Ivenix Infusion System, we expand the combined ...
” Program Updates Presented interim data from Phase 1/2 clinical trial of AVR-RD-04 in cystinosis at the 18th Annual WORLDSymposium™ 2022: First three patients dosed to date remain off oral cysteamine with follow up durations ranging between 12- and 26-months post-gene therapy infusion. Sustained engraftment has been observed in each of these ...
“Advancing medication safety and clinical outcomes is critical for a hospital, and we’re honored to support Deborah Heart’s efforts to protect patient health.” The Ivenix Infusion System includes a large-volume infusion pump, portfolio of administration sets, and infusion management software with unique capabilities for ...
As Senior VP, Drug Delivery, Moberg will lead the development of Bexson's drug delivery technologies, starting with a wearable infusion device for its BB106 therapy, in partnership with Italian drug containment solution and medical device manufacturer, Stevanato Group. ...
Our expansion into functional genomics will help our partners tackle their most pressing questions in therapy development and will ultimately improve the lives of many patients.” By partnering with pharmaceutical, biotech, and academic leaders and building its own pipeline, Immunai is poised to answer the most pressing questions in immuno-oncology, cell ...
ByImmunai
Vascular access technology pioneer Velano Vascular today revealed that the 2021 Infusion Therapy Standards of Practice, 8th Ed., include its needle free PIVO™ device and evidence of the procedure’s improved performance for inpatient blood draws. Updated every five years and considered the preeminent guidance for infusion ...
SAN FRANCISCO, January 25, 2021 — Vascular access technology pioneer Velano Vascular today revealed that the 2021 Infusion Therapy Standards of Practice, 8th Ed., include its needle free PIVO™ device and evidence of the procedure’s improved performance for inpatient blood draws. Updated every five years and considered the preeminent guidance for ...
Atomwise, the leader in using artificial intelligence (AI) for small molecule drug discovery, announced today a partnership with GC Pharma (KRX: 006280), a South Korean biopharmaceutical company formerly known as Green Cross Corporation, to discover and develop novel hemophilia therapies. GC Pharma is a pioneer in vaccines and protein therapeutics and has long been dedicated to ...
"Over the last several years, physicians utilizing implantable pumps to deliver long-term baclofen infusions have only had one device option," said Charles Argoff, M.D., a neurologist at Albany Medical Center in Albany, New York. ...
About the Prometra II Programmable Infusion System The Prometra Programmable Infusion Pump System is indicated for intrathecal infusion of drug therapy, including: Infumorph (preservative free morphine sulfate sterile solution), preservative-free sterile 0.9% saline solution (Sodium Chloride Injection, USP), and baclofen ...
Flowonix Medical, Inc. and Cerebral Therapeutics, Inc. announced today the successful implant of the fifth patient in the ADDRESS (Australian Direct Drug Administration for Refractory Epilepsy) trial. The jointly developed therapy features a micro-infusion device which tightly controls drug delivery to a region of the brain for patients with medically refractory ...
Braun Medical Inc., a leader in infusion therapy and pain management. Intravenous (IV) therapy plays a central role in patient care with as many as 90 percent of hospital patients receiving a peripheral IV catheter as part of their treatment plan. ...
Our own brand of critical care solutions span non-invasive respiratory management, thermoregulation and diagnostics, and patient warming for newborns through to adults in intensive care and the operating theatre, whilst our distribution business supplies solutions to support specialised surgical procedures and infusion therapies. Present in over 75 countries ...
In fact, one of our nurses stated that she feels the VeinViewer is the best purchase we ever made for the ICU,” said Janice Wagner, BSN, RN, CCRN, Director of Intensive Care and Respiratory Therapy. “One of our goals is to keep pace and offer the newest trends in medicine to our community. ...